#USA #Los Angeles #Securities Fraud #Lawsuit #Picard Medical

Investors in Picard Medical, Inc. Have a Chance to Lead Fraud Lawsuit

Overview of the Situation

On February 25, 2026, Glancy Prongay Wolke & Rotter LLP announced significant news for investors in Picard Medical, Inc. (PMI). Those who have suffered financial losses from their investments in the company are encouraged to consider leading a class action lawsuit against it for securities fraud. This opportunity has garnered much attention, particularly among those who feel they have been misled and harmed financially by the company's alleged actions.

Background on the Allegations

The lawsuit centers around claims that between September 2, 2025, and October 31, 2025, Picard Medical, Inc. engaged in unethical practices that misled investors about the company’s true state. Specifically, the allegations include:

1. Misinformation and Fraudulent Promotion: The lawsuit asserts that Picard was involved in a fraudulent stock promotion scheme utilizing social media to disseminate misinformation and impersonate financial professionals. Investors were reportedly led to believe in the value of the stocks based on these misleading promotions.

2. Insider Trading Tactics: It is alleged that insiders and affiliates of Picard used offshore or nominee accounts to execute a coordinated effort to dump shares during a price hike, contributing to the false valuation of the company’s stock during this period.

3. Lack of Transparency: The complaint further claims that significant public statements and disclosures made by Picard failed to mention the existence of false rumors and manipulation of trading activity, which artificially inflated the stock price. This lack of transparency is believed to have misled multiple investors who trusted the company’s announcements.

4. Misleading Positive Statements: The false claims made by the company's representatives regarding the business's operations and future prospects are pointed out as being materially misleading and lacking a solid foundation. This has led many investors to suffer financial losses based on the alleged fraudulent nature of the claims.

How to Participate

For those investors who wish to join the lawsuit, it is essential to note the deadline for action. Interested parties must act before April 3, 2026, to participate in the securities fraud class action. Glancy Prongay Wolke & Rotter LLP has provided clear instructions for affected investors who want to learn more or participate in the proceedings:

• - Contact Charles Linehan, Esq.
• - Reach out via their Los Angeles office by phone or email as listed in the announcement.
• - You may also retain your counsel but it is not required at this moment to be part of the class action.

Conclusion

This opportunity comes as a ray of hope for investors who feel they have been wronged by the practices employed by Picard Medical, Inc. Being part of a class action lawsuit not only allows them a potential path to recover losses but also contributes to holding companies accountable for their actions in the financial markets. Investors are encouraged to consider their options prudently, weigh the benefits, and take appropriate actions within the specified timeframe to ensure their voices are heard in this case.

For more information and to delve deeper into the implications of this lawsuit, interested parties are encouraged to visit the firm's website or follow them on social media for updates. The case underlines the importance of investor awareness and the continuing need for transparency in the realm of corporate finance.